| 6th International Workshop and Conference on Human Leukocyte Differentiation Antigens: Abstracts November 10-14, 1996 Kobe, Japan T Kishimoto, M Miyasaka, D Mason, K Sugamura, T Springer, SM Goyert, ... TISSUE ANTIGENS 48, 1996 | | 1996 |
| 77. antigen-specific modulation of capsid immunogenicity with tolerogenic nanoparticles results in successful AAV vector readministration A Meliani, F Boisgerault, G Ronzitti, F Collaud, C Leborgne, TK Kishimoto, ... Molecular Therapy 24, S34, 2016 | 9 | 2016 |
| A crucial role of map kinase phosphatase-1 (MKP-1) in neuronal death in oxygen glucose deprivation S Koga, S Kojima, T Kishimoto, A Yamaguchi, S Kuwabara Neuroscience Research, e207, 2010 | | 2010 |
| A dynamic model for neutrophil localization to inflammatory sites TK Kishimoto J NIH Res 3 (7), 5-77, 1991 | 91 | 1991 |
| A novel AAV-based therapy in combination with tolerogenic ImmTOR nanoparticles for a sustained treatment of ornithine transcarbamylase deficiency G De Sabbata, F Boisgerault, C Leborgne, F Collaud, A Iaconcig, ... HUMAN GENE THERAPY 30 (11), A150-A151, 2019 | | 2019 |
| A novel approach to gene therapy for methylmalonic acidemia using an ancestral AAV capsid and synthetic vaccine particles containing rapamycin (SVP-R) CP Venditti, RJ Chandler, L Li, E Andres-Mateos, R Xiao, P Ilyinskii, ... MOLECULAR GENETICS AND METABOLISM 123 (3), 273-273, 2018 | | 2018 |
| A pilot study on using rapamycin-carrying synthetic vaccine particles (SVP) in conjunction with enzyme replacement therapy to induce immune tolerance in Pompe disease HH Lim, H Yi, TK Kishimoto, F Gao, B Sun, PS Kishnani Molecular genetics and metabolism reports 13, 18-22, 2017 | 27 | 2017 |
| A small-molecule antagonist of LFA-1 blocks a conformational change important for LFA-1 function JR Woska Jr, D Shih, VR Taqueti, N Hogg, TA Kelly, TK Kishimoto Journal of Leukocyte Biology 70 (2), 329-334, 2001 | 72 | 2001 |
| A strategy to mitigate toxicities associated with AAV doses of 1E14 vg/kg or higher by enabling repeated vector administrations at 5E13 vg/kg PO Ilyinskii, CJ Roy, AM Michaud, GL Rizzo, T Capela, SS Leung, ... HUMAN GENE THERAPY 33 (23-24), A161-A162, 2022 | | 2022 |
| Abbass 0, Hughes B, Rothlein R, McIntire LV, Butcher E, Anderson DC: Chemotactic factors regulate lectin adhesion molecule 1 (LECAM-1)-dependent neutrophil adhesion to cytokine … CW Smith, TK Kishimoto J Clin Invest 87, 609, 1991 | 58 | 1991 |
| Abstract# 5005: M-ONC 402, a novel low molecular weight heparin (LMWH), interacts with heparin-binding proteins and inhibits metastatic seeding of tumor cells in mice CL Chu, J Duffner, N Dussault, A Long, S Roy, E Moy, H Zhou, B Schultes, ... Cancer Research 69 (9_Supplement), 5005-5005, 2009 | | 2009 |
| Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels JA Wedzicha, TAR Seemungal, PK MacCallum, EA Paul, GC Donaldson, ... Thrombosis and haemostasis 84 (08), 210-215, 2000 | 645 | 2000 |
| ADAM17 but not ADAM10 mediates tumor necrosis factor-α and L-selectin shedding from leukocyte membranes TP Condon, S Flournoy, GJ Sawyer, BF Baker, TK Kishimoto, CF Bennett Antisense and Nucleic Acid Drug Development 11 (2), 107-116, 2001 | 106 | 2001 |
| Addressing high dose AAV toxicity–‘one and done’or ‘slower and lower’? TK Kishimoto, RJ Samulski Expert opinion on biological therapy 22 (9), 1067-1071, 2022 | 98 | 2022 |
| Adhesion in Leukocyte Homing and Differentiation D Dunon, CR Mackay, BA Imhof, TK Kishimoto Trends in Cell Biology 4 (9), 342, 1994 | | 1994 |
| Adhesion in leukocyte homing and differentiation: edited by D. Dunon, CR Mackay and BA Imhof, Springer-Verlag, 1993. DM 170.00 (260 pages) ISBN 3 540 56756 9 TK Kishimoto Trends in Cell Biology 4 (9), 342-343, 1994 | | 1994 |
| Adhesion of leukocytes to growing arterial thrombi IA Hagberg, HE Roald, T Lyberg Thrombosis and haemostasis 80 (11), 852-858, 1998 | 58 | 1998 |
| Adhesive Interactions of Neutrophils with Endothelial Cells CW Smith, O Abbassi, SB Shappell, DC Anderson, LV McIntire, ... Host Defense Dysfunction in Trauma, Shock and Sepsis: Mechanisms and …, 1993 | | 1993 |
| Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine … PO Ilyinskii, CJ Roy, CP O’Neil, EA Browning, LA Pittet, DH Altreuter, ... Vaccine 32 (24), 2882-2895, 2014 | 187 | 2014 |
| Adjuvant-carrying targeted Synthetic Vaccine Particles (tSVP™) augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing … P Ilyinskii, C Roy, C O’Neil, E Browning, L Pittet, D Altreuter, K Kishimoto The Journal of Immunology 188 (1_Supplement), 75.3-75.3, 2012 | | 2012 |